Recent patents in siRNA delivery employing nanoparticles as delivery vectors

Recent Patents on DNA and Gene Sequences

Volumn 6, Issue 2, 2012, Pages 91-97

  Nimesh, Surendra ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Biocompatibility; Biodegradability; Cationic; Chitosan; Degradation; Delivery; Lipids; Lipoplexes; Liposome; Nano vectors; Nanoparticles; Polyarginine; Polymer; siRNA; Therapeutic

Indexed keywords

APOLIPOPROTEIN B; CELL PENETRATING PEPTIDE; CHITOSAN; ELASTASE; INTERLEUKIN 8; MAGNETIC NANOPARTICLE; NANOPARTICLE; POLYGLUTAMIC ACID; POLYLACTIDE; QUANTUM DOT; SERUM AMYLOID A; SMALL INTERFERING RNA; VASCULOTROPIN;

AMYLOIDOSIS; ANGIOGENESIS; CELL ORGANELLE; COLON CANCER; DEACETYLATION; DRUG DELIVERY SYSTEM; EYE DISEASE; HUMAN; MOLECULAR WEIGHT; NONHUMAN; PATENT; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW;

EID: 84863977991     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221512801327406     Document Type: Review

References (40)

1. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391(6669): 806-11.
2. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409(6818): 363-6. Epub 2001/02/24.
3. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411(6836): 494-8. Epub 2001/05/25.
4. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNAdirected nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404(6775): 293-6. Epub 2000/04/05.
5. Nykanen A, Haley B, Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 2001; 107(3): 309-21. Epub 2001/11/10.
6. Martinez J, Tuschl T. RISC is a 5' phosphomonoester-producing RNA endonuclease. Genes Dev 2004; 18(9): 975-80. Epub 2004/04/24.
7. Liu J, Carmell MA, Rivas FV, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004; 305(5689): 1437-41. Epub 2004/07/31.
8. Leung RKM, Whittaker PA. RNA interference: From gene silencing to gene-specific therapeutics. Pharmacol Therapeut 2005; 107(2): 222-39.
9. Zhang S, Zhao B, Jiang H, Wang B, Ma B. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 2007; 123(1): 1-10. Epub 2007/08/25.
10. Xu D, McCarty D, Fernandes A, Fisher M, Samulski RJ, Juliano RL. Delivery of MDR1 small interfering RNA by selfcomplementary recombinant adeno-associated virus vector. Mol Ther 2005; 11(4): 523-30. Epub 2005/03/18.
11. Zaiss AK, Muruve DA. Immune responses to adeno-associated virus vectors. Curr Gene Ther 2005; 5(3): 323-31. Epub 2005/06/25.
12. Templeton NS, Lasic DD. New directions in liposome gene delivery. Mol Biotechnol 1999; 11(2): 175-80. Epub 1999/08/28.
13. Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008; 69(1): 1-9. Epub 2007/09/11.
14. Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 2003; 20(2): 212-20. Epub 2003/03/15.
15. Reineke TM. Polyamides for nucleic acid delivery. US Patent 20090/105115, 2004.
16. Manoharan M, Rajeev KG, Akinc A, Jayaprakash NK, Jayraman M, Maier M. Lipid containing formulations. US Patent 8034376, 2011.
17. Kim WJ, Kim SW. Polymeric carrier for delivery of small interfering RNA. US Patent 20100/130722, 2010.
18. Yaworski E, Lam K, Jeffs L, Palmer L, Maclachlan I. Novel lipid formulations for nucleic acid delivery. US Patent 20100/130588, 2009.
19. Lokshin AE, Winans M, Landsittel D, et al. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecol Oncol 2006; 102(2): 244-51. Epub 2006/01/26.
20. Mian BM, Dinney CP, Bermejo CE, et al. Fully human antiinterleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res 2003; 9(8): 3167-75. Epub 2003/08/13.
21. Merritt WM, Sood AK, Bar-eli M, Lopez-berestein G. Therapeutic targeting of interleukins using siRNA in neutral liposomes. US Patent 20100/172962, 2008.
22. Sung H, Chen M, Tu H. Nanoparticles for targeting hepatoma cells and delivery means. US Patent 7, 985, 426, 2011.
23. Rinaudo M. Chitin and chitosan: Properties and applications. Prog Polym Sci 2006; 31(7): 603-32.
24. Artursson PAS, Issa MM, Strand SP, Varum KM. Oligonucleotide Non-Viral Delivery Systems. US Patent 20080/131371, 2007.
25. Kjems J, Howard, Kenneth A, Besenbacher F, Andersen MØ. Dehydrated chitosan nanoparticles. US patent 20110033547, 2011.
26. Viehl CT, Becker-Hapak M, Lewis JS, et al. A tat fusion proteinbased tumor vaccine for breast cancer. Ann Surg Oncol 2005; 12(7): 517-25. Epub 2005/05/13.
27. Noguchi H, Matsushita M, Okitsu T, et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004; 10(3): 305-9. Epub 2004/02/11.
28. Meade BR, Dowdy SF. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev 2007; 59(2-3): 134-40. Epub 2007/04/25.
29. Chatterton JE. Interfering RNA delivery system and uses thereof. US Patent 7879813, 2011.
30. Rana TM, inventor; Delivery of siRNAs. US patent 20110086425, 2011.
31. Gao X. Nanoparticle-amphipol complexes for nucleic acid intracellular delivery and imaging. US Patent 20, 090, 322, 327; 2009.
32. De Fougerolles A, Novobrantseva T, Hinkle G. Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene. US Patent 20110263684 2011.
33. Amiji MM, Iyer, Arun K. Multifunctional self-assembling polymeric nanosystems. US patent 20110244048, 2011.
34. Bowman KA, James PG Jr., George DH, Rubina GP, Chandra V, Weimin W, Ye Z. Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic Acids. US patent 20110224447, 2011.
35. King MR, Huang Z. Compositions and methods for delivery of molecules to selectin-ligand-expressing and selectin-expressing cells. US Patent App. 20100/151573, 2009.
36. Fitzgerald K, De Fougerolles, Antonin A, Akin K, Victor E. Optimized Methods For Delivery Of dsRNA Targeting The PCSK9 Gene. US patent 20100010066, 2010.
37. Lyons RT, Ma Hongwen. ALLERGAN, INC. (Irvine, CA, US), assignee. Methods and composition for intraocular delivery of therapeutic siRNA. US patent 2009022653, 2009.
38. Yu LC, Zhao G, Ma N, Zhao X, Liu J, Tanaka Y. Water soluble crosslinked polymers. US 2008/0312174 A1, 2008.
39. Bhatia SN, Harris T, Agrawal A, Min D, Derfus AM, Von Maltzahn G. Delivery of Nanoparticles and/or Agents to Cells. US Patent App. 20080/213377, 2007.
40. Wagner E, Klockner J, Tarcha P, Merdan T. Chemically modified polycation polymer for siRNA delivery. US patent 20080112916, 2008.